Application Sponsors
Marketing Status
Application Products
| 001 | INJECTABLE;INTRAVENOUS | EQ 4MG BASE/5ML | 0 | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 
FDA Submissions
 | ORIG | 1 | AP | 2013-03-04 |   | 
| LABELING; Labeling | SUPPL | 2 | AP | 2015-03-25 | STANDARD  | 
| LABELING; Labeling | SUPPL | 4 | AP | 2015-03-25 | STANDARD  | 
| LABELING; Labeling | SUPPL | 5 | AP | 2016-03-24 | STANDARD  | 
| LABELING; Labeling | SUPPL | 6 | AP | 2020-02-21 | STANDARD  | 
| LABELING; Labeling | SUPPL | 7 | AP | 2020-02-21 | STANDARD  | 
Submissions Property Types
| ORIG | 1 | Null | 15 | 
| SUPPL | 2 | Null | 7 | 
| SUPPL | 4 | Null | 7 | 
| SUPPL | 5 | Null | 15 | 
| SUPPL | 6 | Null | 15 | 
| SUPPL | 7 | Null | 15 | 
TE Codes
CDER Filings
BRECKENRIDGE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91170
            [companyName] => BRECKENRIDGE
            [docInserts] => ["",""]
            [products] => [{"drugName":"ZOLEDRONIC ACID","activeIngredients":"ZOLEDRONIC ACID","strength":"EQ 4MG BASE\/5ML","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ZOLEDRONIC ACID","submission":"ZOLEDRONIC ACID","actionType":"EQ 4MG BASE\/5ML","submissionClassification":"INJECTABLE;INTRAVENOUS","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )
)